3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasm Metastasis
1
Carcinoma, Squamous Cell
1
Interventions
Cisplatin
8
Radiotherapy
5
Paclitaxel
5
Docetaxel
5
Cetuximab
4
Carboplatin
4
pembrolizumab
3
figitumumab
2
cemiplimab
2
advexin
2
Radiation
2
Methotrexate
2
Fluorouracil
2
Drug Therapy
2
Bleomycin
2
vandetanib
1
talimogene laherparepvec
1
sintilimab
1
nedaplatin
1
nanocis
1
methyl 5-aminolevulinate
1
ficlatuzumab
1
dusquetide
1
brigatinib
1
avasopasem manganese
1
alpha-2'-deoxythioguanosine
1
Vinorelbine
1
Tretinoin
1
Tirapazamine
1
Technetium-99
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Squamous Cell
×
ficlatuzumab
×
Clear all
NCT06064877
2026-04-09
FIERCE-HN
AVEO Pharmaceuticals, Inc.
Phase 3
Recruiting
410 enrolled